Fingerprint
Dive into the research topics where Sattva S Neelapu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma
Kim, K., Shah, R., Ayers, A., Ahmed, S., Claret, L., Strati, P., Nair, R., Nze, C., Ramdial, J., Torres, J., Shpall, E. J., Fayad, L. E., Nastoupil, L. J., Westin, J. R., Flowers, C. R., Neelapu, S. S. & Chihara, D., Mar 2026, In: British Journal of Haematology. 208, 3, p. 992-1000 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/ Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies
Locke, F. L., Munoz, J. L., Tees, M. T., Lekakis, L. J., de Vos, S., Nath, R., Stevens, D. A., Malik, S. A., Shouse, G. P., Hamadani, M., Oluwole, O. O., Perales, M. A., Miklos, D. B., Fisher, P. W., Feng, A., Navale, L., Le Gall, J. B. & Neelapu, S. S., May 10 2025, In: Journal of Clinical Oncology. 43, 14, p. 1695-1705 11 p.Research output: Contribution to journal › Article › peer-review
Open Access29 Link opens in a new tab Scopus citations -
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy
Prasad, R., Rehman, A., Rehman, L., Darbaniyan, F., Blumenberg, V., Schubert, M. L., Mor, U., Zamir, E., Schmidt, S., Hayase, T., Chang, C. C., McDaniel, L., Flores, I., Strati, P., Nair, R., Chihara, D., Fayad, L. E., Ahmed, S., Iyer, S. P. & Wang, M. & 30 others, , Feb 20 2025, In: Blood. 145, 8, p. 823-839 17 p.Research output: Contribution to journal › Article › peer-review
Open Access41 Link opens in a new tab Scopus citations -
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma
Akkad, N., Feng, L., Westin, J. R., Hagemeister, F. B., Lee, H. J., Fayad, L., Ahmed, S., Nair, R., Rodriguez, M. A., Strati, P., Chihara, D., Flowers, C. R., Claret, L., Ibanez, K., Wang, M., Fowler, N. H., Henderson, J., Davis, R. E., Neelapu, S. S. & Green, M. & 1 others, , Sep 9 2025, In: Blood Advances. 9, 17, p. 4396-4404 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma
Strati, P., Feng, L., Tyshevich, A., Shavronskaya, D., Alesse, J., English, N., Sheehan, E., Syzrantsev, N., Nesmelov, A., Zhuang, T. Z., Chihara, D., Westin, J. R., Ahmed, S., Fayad, L. E., Henderson, J., Dent, K., McChesney, E., Neelapu, S. S. & Flowers, C. R., Oct 1 2025, In: Clinical Cancer Research. 31, 19, p. 4079-4088 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations